California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on April 9, 2026

Apr. 9, 2026

Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant

Indeterminate GlobeNewswire

Apr. 9, 2026

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

Indeterminate GlobeNewswire

Apr. 9, 2026

Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer

Indeterminate GlobeNewswire

Apr. 9, 2026

Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner

Indeterminate GlobeNewswire

Apr. 9, 2026

Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases

Indeterminate GlobeNewswire

Apr. 9, 2026

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%

Indeterminate GlobeNewswire

Apr. 9, 2026

Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 9, 2026

Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

BCAN Names Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors of the 2026 Walks to End Bladder Cancer

Indeterminate GlobeNewswire

Apr. 9, 2026

Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event

Indeterminate GlobeNewswire

Apr. 9, 2026

Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 9, 2026

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Indeterminate GlobeNewswire

Apr. 9, 2026

Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members

Indeterminate GlobeNewswire

Apr. 9, 2026

Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire

Apr. 9, 2026

Curonix LLC Announces Appointment of Don Payerle to its Board of Managers, Strengthening Strategic Leadership

Indeterminate GlobeNewswire

Apr. 9, 2026

Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents

Indeterminate GlobeNewswire